Screening of Chinese medicinal plants for inhibition against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA)

Journal of Ethnopharmacology

Volumn 120, Issue 2, 2008, Pages 287-290

  Zuo, G Y ^a   Wang, G C ^a   Zhao, Y B ^a   Xu, G L ^a   Hao, X Y ^b   Han, J ^c   Zhao, Q ^c  

^a KUNMING GENERAL HOSPITAL   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

^c YUNNAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Anti MRSA activity; Betulinic acid; Crude extract; Herbal medicine

Indexed keywords

ANEMONE RIVALRY EXTRACT; BETULIC ACID; BIOTA ORIENTALIS EXTRACT; CONYZA BLINIII EXTRACT; DENDROBENTHAMIA CAPITATA EXTRACT; DICHROCEPHALA CHRYSANTHEMIFOLIA EXTRACT; DUCHESNEA INDICA EXTRACT; ELSHOLTZIA BLANDA EXTRACT; ELSHOLTZIA RUGULOSA EXTRACT; GAULTHERIA YURMANEIISIS EXTRACT; GERANIUM STRICTIPES EXTRACT; KEINECKEA CARNEA EXTRACT; PHYSALIS ALKEKENGI EXTRACT; PLANT EXTRACT; POLYGONUM MULTIFLORUM EXTRACT; POTENTILLA FULGENS EXTRACT; ROSA LAEVIGATA EXTRACT; RUBIA CORDIFOLIA EXTRACT; SCHIZANDRA SPAERARIDRA EXTRACT; SENECIO SCANDENS EXTRACT; TETRASTIGMA HYPOGLAUCUM EXTRACT; UNCLASSIFIED DRUG; VANCOMYCIN;

ANEMONE RIVALRY; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BIOASSAY; BIOTA ORIENTALIS; BROTH DILUTION; CHINESE HERB; CONTROLLED STUDY; CONYZA BLINII; DENDROBENTHAMIA CAPITATA; DICHROCEPHALA CHRYSANTHEMIFOLIA; DRUG SCREENING; DUCHESNA INDICA; ELSHOLTZIA RUGULOSA; GAULTHERIA YURMANEIISIS; GERANIUM STRICTIPES; IN VITRO STUDY; KEINECKEA CARNEA; MEDICINAL PLANT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHYSALIS ALKEKENGI; PHYTOCHEMISTRY; POLYGONUM MULTIFLORUM; POTENTILLA FULGENS; ROSA LAEVIGATA; RUBIA CORDIFOLIA; SCHIZANDRA SPAERARIDRA; SENECIO SCANDENS; TETRASTIGMA HYPOGLAUCUM;

ANTI-BACTERIAL AGENTS; DRUGS, CHINESE HERBAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PLANT EXTRACTS; VANCOMYCIN;

CAPITATA; ELSHOLTZIA BLANDA; ELSHOLTZIA RUGULOSA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POLYGONUM MULTIFLORUM;

EID: 55149118383     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2008.08.021     Document Type: Article

References (26)

1. Anonymous. Selected Yunnan Traditional Chinese Herbs (1970), Tianjin People's Press, Tianjin, China
2. Barrett J.F. MRSA-what is it, and how do we deal with the problem?. Expert Opinion on Therapeutic Targets 9 (2005) 253-265
3. Berger B.B., and Rohrer S. Factors influencing methicillin resistance in Staphylococci. Archives of Microbiology 178 (2002) 165-171
4. Cheng B., Liu I.F., and Dinh Y.C.T. Compounds with antibacterial activity that enhance DNA cleavage by bacterial DNA topoisomerase I. Journal of Antimicrobial Chemotherapy 59 (2007) 640-645
5. Clinical and Laboratory Standards Institute, 2006a. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, seventh ed, vol. M7-A7. Approved Standard. Document M7. CLSI, Wayne, PA.
6. Clinical and Laboratory Standards Institute, 2006b. Performance standards for antimicrobial disk susceptibility tests, ninth ed. Approved Standard. Document M2-A9. CLSI, Wayne, PA.
7. Clinical and Laboratory Standards Institute, 2007. Performance standards for antimicrobial susceptibility testing-17th informational supplement. Approved standard, CLSI document M100-S17. CLSI, Wayne, PA.
8. Deurenberg R.H., Kalenic C., Vink S., Friedrich A.W., Bruggeman C.A., and Stobberingh E.E. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clinical Microbiology and Infection 13 (2007) 222-235
9. Dickson R.A., Houghton P.J., Hyhinds P.J., and Gibbon S. Antimicrobial, resistance-modifying effects, antioxidant and free radical scavenging activities of Mezoneuron benthamianum Bail., Securinega virosa Roxb. and Wlld. and Microglossa pyrifolia Lam. Phytotherapy Research 20 (2006) 41-45
10. Enright M.C. The evolution of a resistant pathogen-the case of MRSA. Current Opinion in Pharmacology 3 (2003) 474-479
11. Giacometti A., Cirioni O., Riva A., Kamysz W., Silvestri C., Nadolski P., Vittoria D.A., Lukasiak J., and Scalise G. In vitro activity of aurein 1.2 alone and in combination with antibiotics against Gram-positive nosocomial cocci. Antimicrobial Agents and Chemotherapy 51 (2007) 1494-1496
12. Gibbons S., Leimkugel J., Oluwatuyi M., and Heinrich M. Activity of Zanthoxylum clava-herculis extracts against multi-drug resistant methicillin-resistant Staphylococcus aureus (mdr-MRSA). Phytotherapy Research 17 (2003) 274-275
13. Goldstein F.W. Combating resistance in a challenging, changing environment. Clinical Microbiology and Infection 13 (2007) 2-6
14. Horiuchi K., Shiot S., Hatno T., Yoshida T., Kuroda T., and Tsuchiya T. Antimicrobial Activity of oleanolic acid from Salvia officinalis and related compounds on vancomycin-resistant enterococci (VRE). Biological Pharmaceutical Bulletin 30 (2007) 1147-1149
15. Kaatz G.W. Bacterial efflux pump inhibition. Current Opinion in Investigation of Drugs 6 (2005) 191-198
16. Kuete V., Wabo G.F., Ngamenib B., Mbaveng A.T., Metunob R., Etoa F.-X., Ngadjui B.T., Benga V.P., Marion Meyer J.J.M., and Lall N. Antimicrobial activity of the methanolic extract, fractions and compounds from the stem bark of Irvingia gabonensis (Ixonanthaceae). Journal of Ethnopharmacology 114 (2007) 54-60
17. Michalet S., Cartier G., David B., Mariotte A.M., franca M.G.D., Kaatz G.W., Stavrid M., and Gibbons S. N-caffeoylphenalkylamide derivatives as bacterial efflux pump inhibitors. Bioorganic and Medicinal Chemistry Letters 17 (2007) 1755-1758
18. National Committee for Clinical Laboratory Standards, 1999. Methods for determining bactericidal activity antimicrobial agents. Approved guidelines. Document M26-A. CLSI (formerly NCCLS), Wayne, PA.
19. Navarro V., and Delgado G. Two antimicrobial alkaloids from Bocconia arborea. Journal of Ethnopharmacology 66 (1999) 223-226
20. Nick A., Wright A.D., Topul R., and Sticher O. Antibacterial triterpenoids from Dillenia papuana and their structure-activity relationships. Phytochemistry 40 (1995) 1691-1695
21. Rzeski W., Stepulak A., Szymański M., Sifringer M., Kaczor K., Wejksza K., Zdzisińska B., and Kandefer-Szerszeń M. Betulinic acid decreases expression of bcl-2 and cyclin D1, inhibits proliferation, migration and induces apoptosis in cancer cells. Naunyn-Schmiedeberg's Archives of Pharmacology 374 (2006) 11-20
22. Schmitz F.J., Fluit A.C., Luckefahr M., Engler B., Hofmann B., Verhoef J., Heinz H.P., Hadding U., and Jones M.E. The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus. Journal of Antimicrobial Chemotherapy 42 (1998) 807-810
23. Stavri M., Piddock L.J., and Gibbons S. Bacterial efflux pump inhibitors from natural sources. Journal of Antimicrobial Chemotherapy 59 (2007) 1247-1260
24. Yogeeswari P., and Sriram D. Betulinic acid and its derivatives: a review on their biological properties. Current Medicinal Chemistry 12 (2005) 657-666
25. Zeng Y.L. Yu-long Pen-ts'ao (Materia Medica of Na-xi Nationality). Chinese Journal of Ethnomedicine and Ethnopharmacy 36 (1999) 1-10
26. Zuo G.Y., Wang G.C., Xu G.L., Yu W., Peng H., and Kuang W.X. Screening of anti-MRSA activity from 30 Chinese herbage medicine extracts. Chinese Journal of Modern Applied Pharmacy 23 (2006) 293-295